Lucid Diagnostics Inc.
LUCD
$1.14
-$0.01-0.87%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 24.19% | 4.13% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 24.19% | 4.13% | |||
| Cost of Revenue | 9.61% | 8.57% | |||
| Gross Profit | 26.75% | -21.50% | |||
| SG&A Expenses | 19.51% | 2.83% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 19.62% | 3.37% | |||
| Operating Income | -19.15% | -3.29% | |||
| Income Before Tax | -56.45% | -134.22% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -56.45% | -134.22% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -56.45% | -134.22% | |||
| EBIT | -19.15% | -3.29% | |||
| EBITDA | -19.61% | -3.38% | |||
| EPS Basic | -28.82% | -20.58% | |||
| Normalized Basic EPS | 1.78% | 5.34% | |||
| EPS Diluted | -28.82% | -20.58% | |||
| Normalized Diluted EPS | 1.78% | 5.34% | |||
| Average Basic Shares Outstanding | 21.46% | 9.28% | |||
| Average Diluted Shares Outstanding | 21.46% | 9.28% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||